MedPath

To study the Effects of the Systane Ultra eye drops in the treatment of Dry eye disease.

Not Applicable
Conditions
Health Condition 1: H00-H59- Diseases of the eye and adnexa
Registration Number
CTRI/2023/05/052176
Lead Sponsor
Alcon Laboratories Ind Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects of 18- 50 years with mild-moderate dry eye and having Ocular Surface Disease Index(OSDI) Questionnaire score of 13-32

Exclusion Criteria

1.Subjects diagnosed to have severe dry eye(OSDI >32)

2.Subjects who have undergone cataract surgery, refractive surgery, or any other ocular surgery

3.Subjects who have used contact lenses within the last 6 months.

4.Subjects who are on treatment with other artificial tear products, other topical drops or previously diagnosed with other ocular

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in symptom scoreTimepoint: 1 MONTH
Secondary Outcome Measures
NameTimeMethod
Improvement in tear film parameters (Schirmerâ??s, NIBUT, Corneal staining scores and keratograph)Timepoint: 1 MONTH
© Copyright 2025. All Rights Reserved by MedPath